Global Adoptive Cell Therapy Market Insights, Forecast to 2028

Q: Who are the key players in the adoptive cell therapy market?

Some of the key players are Novartis, JUNO, Kite, Adaptimmune, Fibrocell, Lineage Cell Therapeutics, BioTime, Vericel Corporation, Regeneus, Anhui Anke Biotechnology, CELLECTIS, NantKwest Inc, SorrentoTherapeutics, Bellicum, China, Novartis AG, Others.

Code: QYRE-Auto-5U1536

Report

February 2022

Pages:108

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Lineage Cell Therapeutics

BioTime

Vericel Corporation

Regeneus

Anhui Anke Biotechnology

Adoptive cell therapy, also known as cellular immunotherapy, is a form of treatment that uses the cells of our immune system to eliminate cancer.

Market Analysis and Insights: Global Adoptive Cell Therapy Market

The global Adoptive Cell Therapy market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, CAR-T accounting for % of the Adoptive Cell Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Lymphoma segment is altered to an % CAGR throughout this forecast period.

China Adoptive Cell Therapy market size is valued at US$ million in 2021, while the North America and Europe Adoptive Cell Therapy are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Adoptive Cell Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Adoptive Cell Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Adoptive Cell Therapy market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Adoptive Cell Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Adoptive Cell Therapy market.

Global Adoptive Cell Therapy Scope and Market Size

Adoptive Cell Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Adoptive Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

CAR-T

TCR-T

TIL

Segment by Application

Lymphoma

Leukemia

BY COMPANY

Novartis

Juno

Kite

Adaptimmune

Fibrocell

Lineage Cell Therapeutics

BioTime

Vericel Corporation

Regeneus

Anhui Anke Biotechnology

Cellectis

NantKwest

SorrentoTherapeutics

Bellicum

BY REGION

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

FEATURED COMPANIES

Lineage Cell Therapeutics

BioTime

Vericel Corporation

Regeneus

Anhui Anke Biotechnology

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Adoptive Cell Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 CAR-T

1.2.3 TCR-T

1.2.4 NK

1.2.5 TIL

1.3 Market by Application

1.3.1 Global Adoptive Cell Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Lymphoma

1.3.3 Leukemia

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Adoptive Cell Therapy Market Perspective (2017-2028)

2.2 Adoptive Cell Therapy Growth Trends by Region

2.2.1 Adoptive Cell Therapy Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Adoptive Cell Therapy Historic Market Size by Region (2017-2022)

2.2.3 Adoptive Cell Therapy Forecasted Market Size by Region (2023-2028)

2.3 Adoptive Cell Therapy Market Dynamics

2.3.1 Adoptive Cell Therapy Industry Trends

2.3.2 Adoptive Cell Therapy Market Drivers

2.3.3 Adoptive Cell Therapy Market Challenges

2.3.4 Adoptive Cell Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Adoptive Cell Therapy Players by Revenue

3.1.1 Global Top Adoptive Cell Therapy Players by Revenue (2017-2022)

3.1.2 Global Adoptive Cell Therapy Revenue Market Share by Players (2017-2022)

3.2 Global Adoptive Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Adoptive Cell Therapy Revenue

3.4 Global Adoptive Cell Therapy Market Concentration Ratio

3.4.1 Global Adoptive Cell Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Adoptive Cell Therapy Revenue in 2021

3.5 Adoptive Cell Therapy Key Players Head office and Area Served

3.6 Key Players Adoptive Cell Therapy Product Solution and Service

3.7 Date of Enter into Adoptive Cell Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Adoptive Cell Therapy Breakdown Data by Type

4.1 Global Adoptive Cell Therapy Historic Market Size by Type (2017-2022)

4.2 Global Adoptive Cell Therapy Forecasted Market Size by Type (2023-2028)

5 Adoptive Cell Therapy Breakdown Data by Application

5.1 Global Adoptive Cell Therapy Historic Market Size by Application (2017-2022)

5.2 Global Adoptive Cell Therapy Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Adoptive Cell Therapy Market Size (2017-2028)

6.2 North America Adoptive Cell Therapy Market Size by Type

6.2.1 North America Adoptive Cell Therapy Market Size by Type (2017-2022)

6.2.2 North America Adoptive Cell Therapy Market Size by Type (2023-2028)

6.2.3 North America Adoptive Cell Therapy Market Share by Type (2017-2028)

6.3 North America Adoptive Cell Therapy Market Size by Application

6.3.1 North America Adoptive Cell Therapy Market Size by Application (2017-2022)

6.3.2 North America Adoptive Cell Therapy Market Size by Application (2023-2028)

6.3.3 North America Adoptive Cell Therapy Market Share by Application (2017-2028)

6.4 North America Adoptive Cell Therapy Market Size by Country

6.4.1 North America Adoptive Cell Therapy Market Size by Country (2017-2022)

6.4.2 North America Adoptive Cell Therapy Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Adoptive Cell Therapy Market Size (2017-2028)

7.2 Europe Adoptive Cell Therapy Market Size by Type

7.2.1 Europe Adoptive Cell Therapy Market Size by Type (2017-2022)

7.2.2 Europe Adoptive Cell Therapy Market Size by Type (2023-2028)

7.2.3 Europe Adoptive Cell Therapy Market Share by Type (2017-2028)

7.3 Europe Adoptive Cell Therapy Market Size by Application

7.3.1 Europe Adoptive Cell Therapy Market Size by Application (2017-2022)

7.3.2 Europe Adoptive Cell Therapy Market Size by Application (2023-2028)

7.3.3 Europe Adoptive Cell Therapy Market Share by Application (2017-2028)

7.4 Europe Adoptive Cell Therapy Market Size by Country

7.4.1 Europe Adoptive Cell Therapy Market Size by Country (2017-2022)

7.4.2 Europe Adoptive Cell Therapy Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Adoptive Cell Therapy Market Size (2017-2028)

8.2 Asia-Pacific Adoptive Cell Therapy Market Size by Type

8.2.1 Asia-Pacific Adoptive Cell Therapy Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Adoptive Cell Therapy Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Adoptive Cell Therapy Market Share by Type (2017-2028)

8.3 Asia-Pacific Adoptive Cell Therapy Market Size by Application

8.3.1 Asia-Pacific Adoptive Cell Therapy Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Adoptive Cell Therapy Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Adoptive Cell Therapy Market Share by Application (2017-2028)

8.4 Asia-Pacific Adoptive Cell Therapy Market Size by Region

8.4.1 Asia-Pacific Adoptive Cell Therapy Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Adoptive Cell Therapy Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Adoptive Cell Therapy Market Size (2017-2028)

9.2 Latin America Adoptive Cell Therapy Market Size by Type

9.2.1 Latin America Adoptive Cell Therapy Market Size by Type (2017-2022)

9.2.2 Latin America Adoptive Cell Therapy Market Size by Type (2023-2028)

9.2.3 Latin America Adoptive Cell Therapy Market Share by Type (2017-2028)

9.3 Latin America Adoptive Cell Therapy Market Size by Application

9.3.1 Latin America Adoptive Cell Therapy Market Size by Application (2017-2022)

9.3.2 Latin America Adoptive Cell Therapy Market Size by Application (2023-2028)

9.3.3 Latin America Adoptive Cell Therapy Market Share by Application (2017-2028)

9.4 Latin America Adoptive Cell Therapy Market Size by Country

9.4.1 Latin America Adoptive Cell Therapy Market Size by Country (2017-2022)

9.4.2 Latin America Adoptive Cell Therapy Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Adoptive Cell Therapy Market Size (2017-2028)

10.2 Middle East & Africa Adoptive Cell Therapy Market Size by Type

10.2.1 Middle East & Africa Adoptive Cell Therapy Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Adoptive Cell Therapy Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Adoptive Cell Therapy Market Share by Type (2017-2028)

10.3 Middle East & Africa Adoptive Cell Therapy Market Size by Application

10.3.1 Middle East & Africa Adoptive Cell Therapy Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Adoptive Cell Therapy Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Adoptive Cell Therapy Market Share by Application (2017-2028)

10.4 Middle East & Africa Adoptive Cell Therapy Market Size by Country

10.4.1 Middle East & Africa Adoptive Cell Therapy Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Adoptive Cell Therapy Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Novartis

11.1.1 Novartis Company Details

11.1.2 Novartis Business Overview

11.1.3 Novartis Adoptive Cell Therapy Introduction

11.1.4 Novartis Revenue in Adoptive Cell Therapy Business (2017-2022)

11.1.5 Novartis Recent Developments

11.2 Juno

11.2.1 Juno Company Details

11.2.2 Juno Business Overview

11.2.3 Juno Adoptive Cell Therapy Introduction

11.2.4 Juno Revenue in Adoptive Cell Therapy Business (2017-2022)

11.2.5 Juno Recent Developments

11.3 Kite

11.3.1 Kite Company Details

11.3.2 Kite Business Overview

11.3.3 Kite Adoptive Cell Therapy Introduction

11.3.4 Kite Revenue in Adoptive Cell Therapy Business (2017-2022)

11.3.5 Kite Recent Developments

11.4 Adaptimmune

11.4.1 Adaptimmune Company Details

11.4.2 Adaptimmune Business Overview

11.4.3 Adaptimmune Adoptive Cell Therapy Introduction

11.4.4 Adaptimmune Revenue in Adoptive Cell Therapy Business (2017-2022)

11.4.5 Adaptimmune Recent Developments

11.5 Fibrocell

11.5.1 Fibrocell Company Details

11.5.2 Fibrocell Business Overview

11.5.3 Fibrocell Adoptive Cell Therapy Introduction

11.5.4 Fibrocell Revenue in Adoptive Cell Therapy Business (2017-2022)

11.5.5 Fibrocell Recent Developments

11.6 Lineage Cell Therapeutics

11.6.1 Lineage Cell Therapeutics Company Details

11.6.2 Lineage Cell Therapeutics Business Overview

11.6.3 Lineage Cell Therapeutics Adoptive Cell Therapy Introduction

11.6.4 Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2017-2022)

11.6.5 Lineage Cell Therapeutics Recent Developments

11.7 BioTime

11.7.1 BioTime Company Details

11.7.2 BioTime Business Overview

11.7.3 BioTime Adoptive Cell Therapy Introduction

11.7.4 BioTime Revenue in Adoptive Cell Therapy Business (2017-2022)

11.7.5 BioTime Recent Developments

11.8 Vericel Corporation

11.8.1 Vericel Corporation Company Details

11.8.2 Vericel Corporation Business Overview

11.8.3 Vericel Corporation Adoptive Cell Therapy Introduction

11.8.4 Vericel Corporation Revenue in Adoptive Cell Therapy Business (2017-2022)

11.8.5 Vericel Corporation Recent Developments

11.9 Regeneus

11.9.1 Regeneus Company Details

11.9.2 Regeneus Business Overview

11.9.3 Regeneus Adoptive Cell Therapy Introduction

11.9.4 Regeneus Revenue in Adoptive Cell Therapy Business (2017-2022)

11.9.5 Regeneus Recent Developments

11.10 Anhui Anke Biotechnology

11.10.1 Anhui Anke Biotechnology Company Details

11.10.2 Anhui Anke Biotechnology Business Overview

11.10.3 Anhui Anke Biotechnology Adoptive Cell Therapy Introduction

11.10.4 Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2017-2022)

11.10.5 Anhui Anke Biotechnology Recent Developments

11.11 Cellectis

11.11.1 Cellectis Company Details

11.11.2 Cellectis Business Overview

11.11.3 Cellectis Adoptive Cell Therapy Introduction

11.11.4 Cellectis Revenue in Adoptive Cell Therapy Business (2017-2022)

11.11.5 Cellectis Recent Developments

11.12 NantKwest

11.12.1 NantKwest Company Details

11.12.2 NantKwest Business Overview

11.12.3 NantKwest Adoptive Cell Therapy Introduction

11.12.4 NantKwest Revenue in Adoptive Cell Therapy Business (2017-2022)

11.12.5 NantKwest Recent Developments

11.13 SorrentoTherapeutics

11.13.1 SorrentoTherapeutics Company Details

11.13.2 SorrentoTherapeutics Business Overview

11.13.3 SorrentoTherapeutics Adoptive Cell Therapy Introduction

11.13.4 SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2017-2022)

11.13.5 SorrentoTherapeutics Recent Developments

11.14 Bellicum

11.14.1 Bellicum Company Details

11.14.2 Bellicum Business Overview

11.14.3 Bellicum Adoptive Cell Therapy Introduction

11.14.4 Bellicum Revenue in Adoptive Cell Therapy Business (2017-2022)

11.14.5 Bellicum Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Lineage Cell Therapeutics

BioTime

Vericel Corporation

Regeneus

Anhui Anke Biotechnology

List of Tables

Table 1. Global Adoptive Cell Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of CAR-T

Table 3. Key Players of TCR-T

Table 4. Key Players of NK

Table 5. Key Players of TIL

Table 6. Global Adoptive Cell Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 7. Global Adoptive Cell Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 8. Global Adoptive Cell Therapy Market Size by Region (2017-2022) & (US$ Million)

Table 9. Global Adoptive Cell Therapy Market Share by Region (2017-2022)

Table 10. Global Adoptive Cell Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 11. Global Adoptive Cell Therapy Market Share by Region (2023-2028)

Table 12. Adoptive Cell Therapy Market Trends

Table 13. Adoptive Cell Therapy Market Drivers

Table 14. Adoptive Cell Therapy Market Challenges

Table 15. Adoptive Cell Therapy Market Restraints

Table 16. Global Adoptive Cell Therapy Revenue by Players (2017-2022) & (US$ Million)

Table 17. Global Adoptive Cell Therapy Revenue Share by Players (2017-2022)

Table 18. Global Top Adoptive Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cell Therapy as of 2021)

Table 19. Ranking of Global Top Adoptive Cell Therapy Companies by Revenue (US$ Million) in 2021

Table 20. Global 5 Largest Players Market Share by Adoptive Cell Therapy Revenue (CR5 and HHI) & (2017-2022)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Adoptive Cell Therapy Product Solution and Service

Table 23. Date of Enter into Adoptive Cell Therapy Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Adoptive Cell Therapy Market Size by Type (2017-2022) & (US$ Million)

Table 26. Global Adoptive Cell Therapy Revenue Market Share by Type (2017-2022)

Table 27. Global Adoptive Cell Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 28. Global Adoptive Cell Therapy Revenue Market Share by Type (2023-2028)

Table 29. Global Adoptive Cell Therapy Market Size by Application (2017-2022) & (US$ Million)

Table 30. Global Adoptive Cell Therapy Revenue Share by Application (2017-2022)

Table 31. Global Adoptive Cell Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 32. Global Adoptive Cell Therapy Revenue Share by Application (2023-2028)

Table 33. North America Adoptive Cell Therapy Market Size by Type (2017-2022) & (US$ Million)

Table 34. North America Adoptive Cell Therapy Market Size by Type (2023-2028) & (US$ Million)

Table 35. North America Adoptive Cell Therapy Market Size by Application (2017-2022) & (US$ Million)

Table 36. North America Adoptive Cell Therapy Market Size by Application (2023-2028) & (US$ Million)

Table 37. North America Adoptive Cell Therapy Market Size by Country (2017-2022) & (US$ Million)

Table 38. North America Adoptive Cell Therapy Market Size by Country (2023-2028) & (US$ Million)

Table 39. Europe Adoptive Cell Therapy Market Size by Type (2017-2022) & (US$ Million)

Table 40. Europe Adoptive Cell Therapy Market Size by Type (2023-2028) & (US$ Million)

Table 41. Europe Adoptive Cell Therapy Market Size by Application (2017-2022) & (US$ Million)

Table 42. Europe Adoptive Cell Therapy Market Size by Application (2023-2028) & (US$ Million)

Table 43. Europe Adoptive Cell Therapy Market Size by Country (2017-2022) & (US$ Million)

Table 44. Europe Adoptive Cell Therapy Market Size by Country (2023-2028) & (US$ Million)

Table 45. Asia Pacific Adoptive Cell Therapy Market Size by Type (2017-2022) & (US$ Million)

Table 46. Asia Pacific Adoptive Cell Therapy Market Size by Type (2023-2028) & (US$ Million)

Table 47. Asia Pacific Adoptive Cell Therapy Market Size by Application (2017-2022) & (US$ Million)

Table 48. Asia Pacific Adoptive Cell Therapy Market Size by Application (2023-2028) & (US$ Million)

Table 49. Asia Pacific Adoptive Cell Therapy Market Size by Region (2017-2022) & (US$ Million)

Table 50. Asia Pacific Adoptive Cell Therapy Market Size by Region (2023-2028) & (US$ Million)

Table 51. Latin America Adoptive Cell Therapy Market Size by Type (2017-2022) & (US$ Million)

Table 52. Latin America Adoptive Cell Therapy Market Size by Type (2023-2028) & (US$ Million)

Table 53. Latin America Adoptive Cell Therapy Market Size by Application (2017-2022) & (US$ Million)

Table 54. Latin America Adoptive Cell Therapy Market Size by Application (2023-2028) & (US$ Million)

Table 55. Latin America Adoptive Cell Therapy Market Size by Country (2017-2022) & (US$ Million)

Table 56. Latin America Adoptive Cell Therapy Market Size by Country (2023-2028) & (US$ Million)

Table 57. Middle East and Africa Adoptive Cell Therapy Market Size by Type (2017-2022) & (US$ Million)

Table 58. Middle East and Africa Adoptive Cell Therapy Market Size by Type (2023-2028) & (US$ Million)

Table 59. Middle East and Africa Adoptive Cell Therapy Market Size by Application (2017-2022) & (US$ Million)

Table 60. Middle East and Africa Adoptive Cell Therapy Market Size by Application (2023-2028) & (US$ Million)

Table 61. Middle East and Africa Adoptive Cell Therapy Market Size by Country (2017-2022) & (US$ Million)

Table 62. Middle East and Africa Adoptive Cell Therapy Market Size by Country (2023-2028) & (US$ Million)

Table 63. Novartis Company Details

Table 64. Novartis Business Overview

Table 65. Novartis Adoptive Cell Therapy Product

Table 66. Novartis Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)

Table 67. Novartis Recent Developments

Table 68. Juno Company Details

Table 69. Juno Business Overview

Table 70. Juno Adoptive Cell Therapy Product

Table 71. Juno Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)

Table 72. Juno Recent Developments

Table 73. Kite Company Details

Table 74. Kite Business Overview

Table 75. Kite Adoptive Cell Therapy Product

Table 76. Kite Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)

Table 77. Kite Recent Developments

Table 78. Adaptimmune Company Details

Table 79. Adaptimmune Business Overview

Table 80. Adaptimmune Adoptive Cell Therapy Product

Table 81. Adaptimmune Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)

Table 82. Adaptimmune Recent Developments

Table 83. Fibrocell Company Details

Table 84. Fibrocell Business Overview

Table 85. Fibrocell Adoptive Cell Therapy Product

Table 86. Fibrocell Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)

Table 87. Fibrocell Recent Developments

Table 88. Lineage Cell Therapeutics Company Details

Table 89. Lineage Cell Therapeutics Business Overview

Table 90. Lineage Cell Therapeutics Adoptive Cell Therapy Product

Table 91. Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)

Table 92. Lineage Cell Therapeutics Recent Developments

Table 93. BioTime Company Details

Table 94. BioTime Business Overview

Table 95. BioTime Adoptive Cell Therapy Product

Table 96. BioTime Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)

Table 97. BioTime Recent Developments

Table 98. Vericel Corporation Company Details

Table 99. Vericel Corporation Business Overview

Table 100. Vericel Corporation Adoptive Cell Therapy Product

Table 101. Vericel Corporation Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)

Table 102. Vericel Corporation Recent Developments

Table 103. Regeneus Company Details

Table 104. Regeneus Business Overview

Table 105. Regeneus Adoptive Cell Therapy Product

Table 106. Regeneus Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)

Table 107. Regeneus Recent Developments

Table 108. Anhui Anke Biotechnology Company Details

Table 109. Anhui Anke Biotechnology Business Overview

Table 110. Anhui Anke Biotechnology Adoptive Cell Therapy Product

Table 111. Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)

Table 112. Anhui Anke Biotechnology Recent Developments

Table 113. Cellectis Company Details

Table 114. Cellectis Business Overview

Table 115. Cellectis Adoptive Cell Therapy Product

Table 116. Cellectis Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)

Table 117. Cellectis Recent Developments

Table 118. NantKwest Company Details

Table 119. NantKwest Business Overview

Table 120. NantKwest Adoptive Cell Therapy Product

Table 121. NantKwest Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)

Table 122. NantKwest Recent Developments

Table 123. SorrentoTherapeutics Company Details

Table 124. SorrentoTherapeutics Business Overview

Table 125. SorrentoTherapeutics Adoptive Cell Therapy Product

Table 126. SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)

Table 127. SorrentoTherapeutics Recent Developments

Table 128. Bellicum Company Details

Table 129. Bellicum Business Overview

Table 130. Bellicum Adoptive Cell Therapy Product

Table 131. Bellicum Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)

Table 132. Bellicum Recent Developments

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Adoptive Cell Therapy Market Share by Type: 2021 VS 2028

Figure 2. CAR-T Features

Figure 3. TCR-T Features

Figure 4. NK Features

Figure 5. TIL Features

Figure 6. Global Adoptive Cell Therapy Market Share by Application: 2021 VS 2028

Figure 7. Lymphoma Case Studies

Figure 8. Leukemia Case Studies

Figure 9. Adoptive Cell Therapy Report Years Considered

Figure 10. Global Adoptive Cell Therapy Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 11. Global Adoptive Cell Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 12. Global Adoptive Cell Therapy Market Share by Region: 2021 VS 2028

Figure 13. Global Adoptive Cell Therapy Market Share by Players in 2021

Figure 14. Global Top Adoptive Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cell Therapy as of 2021)

Figure 15. The Top 10 and 5 Players Market Share by Adoptive Cell Therapy Revenue in 2021

Figure 16. North America Adoptive Cell Therapy Market Size YoY (2017-2028) & (US$ Million)

Figure 17. North America Adoptive Cell Therapy Market Size Market Share by Type (2017-2028)

Figure 18. North America Adoptive Cell Therapy Market Size Market Share by Application (2017-2028)

Figure 19. North America Adoptive Cell Therapy Market Size Share by Country (2017-2028)

Figure 20. United States Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 21. Canada Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 22. Europe Adoptive Cell Therapy Market Size YoY (2017-2028) & (US$ Million)

Figure 23. Europe Adoptive Cell Therapy Market Size Market Share by Type (2017-2028)

Figure 24. Europe Adoptive Cell Therapy Market Size Market Share by Application (2017-2028)

Figure 25. Europe Adoptive Cell Therapy Market Size Share by Country (2017-2028)

Figure 26. Germany Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 27. France Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 28. U.K. Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 29. Italy Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. Russia Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. Nordic Countries Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 32. Asia-Pacific Adoptive Cell Therapy Market Size YoY (2017-2028) & (US$ Million)

Figure 33. Asia Pacific Adoptive Cell Therapy Market Size Market Share by Type (2017-2028)

Figure 34. Asia Pacific Adoptive Cell Therapy Market Size Market Share by Application (2017-2028)

Figure 35. Asia Pacific Adoptive Cell Therapy Market Size Share by Region (2017-2028)

Figure 36. China Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 37. Japan Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 38. South Korea Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 39. Southeast Asia Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. India Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 41. Australia Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

Figure 42. Latin America Adoptive Cell Therapy Market Size YoY (2017-2028) & (US$ Million)

Figure 43. Latin America Adoptive Cell Therapy Market Size Market Share by Type (2017-2028)

Figure 44. Latin America Adoptive Cell Therapy Market Size Market Share by Application (2017-2028)

Figure 45. Latin America Adoptive Cell Therapy Market Size Share by Country (2017-2028)

Figure 46. Mexico Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 47. Brazil Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 48. Middle East & Africa Adoptive Cell Therapy Market Size YoY (2017-2028) & (US$ Million)

Figure 49. Middle East and Africa Adoptive Cell Therapy Market Size Market Share by Type (2017-2028)

Figure 50. Middle East and Africa Adoptive Cell Therapy Market Size Market Share by Application (2017-2028)

Figure 51. Middle East and Africa Adoptive Cell Therapy Market Size Share by Country (2017-2028)

Figure 52. Turkey Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 53. Saudi Arabia Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 54. UAE Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 55. Novartis Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)

Figure 56. Juno Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)

Figure 57. Kite Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)

Figure 58. Adaptimmune Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)

Figure 59. Fibrocell Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)

Figure 60. Lineage Cell Therapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)

Figure 61. BioTime Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)

Figure 62. Vericel Corporation Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)

Figure 63. Regeneus Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)

Figure 64. Anhui Anke Biotechnology Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)

Figure 65. Cellectis Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)

Figure 66. NantKwest Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)

Figure 67. SorrentoTherapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)

Figure 68. Bellicum Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Adoptive Cell Therapy Market Insights, Forecast to 2028

Published Date: February 2022

Report Code: QYRE-Auto-5U1536

Global Adoptive Cell Therapy Market Insights, Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-38E10402

Sun Apr 07 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-6B2891

Tue Apr 02 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-34N12630

Tue Mar 26 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-8X13846

Tue Mar 26 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions